Atlas Trials

Clinical Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia

Clinical trial NCT05522192 · UNKNOWN

Trial details

NCT number
NCT05522192
Sponsor
Hui Zeng
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapsed or Refractory Acute Myeloid Leukemia
Start date
2022-07-21
Primary completion
2025-11-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.